Literature DB >> 16696006

Absence of c-Ki-ras gene mutation in malignant and premalignant Barrett's oesophagus.

C Lagorce1, J F Fléjou, F Muzeau, D Hénin, F Potet.   

Abstract

Aims-To establish the prevalence of c-Ki-ras gene mutations in codons 12 and 13 in 28 surgically resected Barrett's adenocarcinomas and 18 associated preneoplastic lesions in Barrett's oesophagus.Methods-Mutations were detected using the polymerase chain reaction followed by restriction fragment length polymorphism analysis. Human colon carcinoma cell lines with well characterised mutations in codons 12 and 13 were used as positive controls and to test the sensitivity of the method.Results-c-Ki-ras gene mutations were not detected in any of the 28 specimens of Barrett's adenocarcinoma or in the 18 specimens of Barrett's oesophagus (nine non-dysplastic cases, three cases with low and six with high grade dysplasia).Conclusions-These results suggest that the c-Ki-ras gene is not involved in the development of cancer in Barrett's oesophagus.

Entities:  

Year:  1995        PMID: 16696006      PMCID: PMC407962          DOI: 10.1136/mp.48.4.m198

Source DB:  PubMed          Journal:  Clin Mol Pathol        ISSN: 1355-2910


  10 in total

Review 1.  Barrett's oesophagus.

Authors:  J Dent; C G Bremner; M J Collen; R C Haggitt; S J Spechler
Journal:  J Gastroenterol Hepatol       Date:  1991 Jan-Feb       Impact factor: 4.029

2.  c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma.

Authors:  G C Burmer; D S Levine; B G Kulander; R C Haggitt; C E Rubin; P S Rabinovitch
Journal:  Gastroenterology       Date:  1990-08       Impact factor: 22.682

Review 3.  Function and regulation of ras.

Authors:  D R Lowy; B M Willumsen
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

4.  Genetic alterations during colorectal-tumor development.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; S E Kern; A C Preisinger; M Leppert; Y Nakamura; R White; A M Smits; J L Bos
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

5.  Activation of c-Ki-ras in human gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products.

Authors:  S J Meltzer; S M Mane; P K Wood; J H Resau; C Newkirk; J A Terzakis; B I Korelitz; W M Weinstein; S W Needleman
Journal:  Cancer Res       Date:  1990-06-15       Impact factor: 12.701

6.  Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer.

Authors:  W Jiang; S M Kahn; J G Guillem; S H Lu; I B Weinstein
Journal:  Oncogene       Date:  1989-07       Impact factor: 9.867

7.  Differential expression of c-myc and H-ras oncogenes in Barrett's epithelium. A study using colorimetric in situ hybridization.

Authors:  O M Abdelatif; F W Chandler; L R Mills; B S McGuire; C G Pantazis; J M Barrett
Journal:  Arch Pathol Lab Med       Date:  1991-09       Impact factor: 5.534

8.  p53 and ras gene expression in human esophageal cancer and Barrett's epithelium: a prospective study.

Authors:  K Sorsdahl; A G Casson; M Troster; D Van Meyel; R Inculet; A F Chambers
Journal:  Cancer Detect Prev       Date:  1994

9.  p53 point mutations in dysplastic and cancerous ulcerative colitis lesions.

Authors:  J Yin; N Harpaz; Y Tong; Y Huang; J Laurin; B D Greenwald; M Hontanosas; C Newkirk; S J Meltzer
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682

10.  TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus.

Authors:  R Hamelin; J F Fléjou; F Muzeau; F Potet; P Laurent-Puig; F Fékété; G Thomas
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

  10 in total
  1 in total

1.  Expression of inflammatory secretory phospholipase A2 and cytosolic phospholipase A2 in premalignant and malignant Barrett's oesophagus.

Authors:  Christine Lagorce-Pagès; François Paraf; Dominique Wendum; Antoine Martin; Jean-François Fléjou
Journal:  Virchows Arch       Date:  2004-03-25       Impact factor: 4.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.